Company Filing History:
Years Active: 2014
Title: The Innovations of Siegfried Schaefer
Introduction
Siegfried Schaefer is a notable inventor based in Munich, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that enhance lipolytic activity. His work is particularly relevant for individuals suffering from maldigestion due to pancreatic insufficiency.
Latest Patents
Schaefer holds a patent for "Pharmaceutical compositions of lipase-containing products, in particular of pancreatin." This invention focuses on orally administrable pharmaceutical compositions that contain lipase products, especially those derived from microbial sources. The compositions are designed to improve lipolytic activity and stabilize lipase in acidic pH environments. They are particularly effective in treating maldigestion, especially in cases of chronic exocrine pancreatic insufficiency in both mammals and humans.
Career Highlights
Siegfried Schaefer is associated with Abbott Products GmbH, where he has been instrumental in advancing pharmaceutical innovations. His expertise in enzyme products has positioned him as a key figure in the development of effective treatments for digestive disorders.
Collaborations
Schaefer has collaborated with notable colleagues such as George Shlieout and Bernd Boedecker. These partnerships have contributed to the successful development and implementation of his innovative pharmaceutical compositions.
Conclusion
Siegfried Schaefer's contributions to the field of pharmaceuticals, particularly through his patent on lipase-containing products, highlight his role as an influential inventor. His work continues to impact the treatment of digestive disorders, showcasing the importance of innovation in healthcare.